Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.

10.1002/jha2.548

Saved in:

書目詳細資料
Main Authors:	Spencer, Andrew, Samoilova, Olga, Chng, Wee-Joo, Labotka, Richard, Li, Cong, Wu, Kwang-Wei, Saxena, Nakul, Yan, Xu, Lee, Jae Hoon, Beksac, Meral
其他作者:	CANCER SCIENCE INSTITUTE OF SINGAPORE
格式:	Article
出版:	Wiley 2023
主題:	emerging‐markets ixazomib multiple myeloma overall survival proteasome inhibitor
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/237497
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study
由: Gupta, N, et al.
出版: (2020)

Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
由: Dimopoulos, Meletios A, et al.
出版: (2022)

Management of treatment-emergent peripheral neuropathy in multiple myeloma
由: Richardson, P.G., et al.
出版: (2016)

Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma.
由: Zhou, Jianbiao, et al.
出版: (2022)

A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma
由: Chng, WJ, et al.
出版: (2023)

The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: An analysis of the Singapore multiple myeloma study group
由: Tan, D., et al.
出版: (2016)

Epigenetic silencing of miR-340-5p in multiple myeloma: Mechanisms and prognostic impact
由: Li, Z., et al.
出版: (2021)

Centrosomes and myeloma; aneuploidy and proliferation
由: Chng, W.J., et al.
出版: (2016)

Natural history and prognostic factors at first relapse in multiple myeloma
由: Wang, C., et al.
出版: (2021)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
由: Davies, FE, et al.
出版: (2023)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
由: Davies, FE, et al.
出版: (2023)

Extramedullary plasmacytoma of the orbit as initial presentation of multiple myeloma
由: Razak, R.A., et al.
出版: (2016)

The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): A joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network
由: Tan, D., et al.
出版: (2016)

CHARACTERISING THE METABOLIC PHENOTYPE OF C-MAF OVEREXPRESSION IN MULTIPLE MYELOMA
由: LIM SZE LYNN JULIA
出版: (2024)

MANAGING UNCERTAINTY IN ONCOLOGY DRUG ASSESSMENTS: APPLICATIONS IN MULTIPLE MYELOMA
由: DIANA BEATRIZ SAMSON BAYANI
出版: (2024)

Epigenetic silencing of long non-coding RNABM742401in multiple myeloma: impact on prognosis and myeloma dissemination
由: Li, Zhenhai, et al.
出版: (2022)

Activities of the cytokine receptor CD137 in multiple myeloma
由: KOH LIANG KAI
出版: (2010)

Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma
由: Chng, W.-J., et al.
出版: (2014)

Multiple Myeloma-Associated Light Chain Amyloidosis and a Proposed Approach to Monoclonal Immunoglobulin-Associated Renal Disease
由: Zi Yun Chang, et al.
出版: (2020)

A unique rhinologic manifestation of multiple myeloma
由: Seah, Jun Jie, et al.
出版: (2022)

Transmembrane activator and caml interactor (Taci): Another potential target for immunotherapy of multiple myeloma?
由: Xu, S., et al.
出版: (2021)

Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival
由: Reghunathan, R., et al.
出版: (2014)

Qualitative study of factors affecting patient, caregiver and physician preferences for treatment of myeloma and indolent lymphoma
由: Jen, W.-Y., et al.
出版: (2021)

Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in t(4;14) multiple myeloma
由: Xie, Z., et al.
出版: (2014)

Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma
由: Goldschmidt, Hartmut, et al.
出版: (2022)

PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL
由: Ueno, S., et al.
出版: (2011)

Attenuation of STAT3 signaling cascade by daidzin can enhance the apoptotic potential of bortezomib against multiple myeloma
由: Yang, M.H., et al.
出版: (2021)

Suppression of essential pro-inflammatory signaling pathways by natural agents for the therapy of multiple myeloma
由: Sikka, S., et al.
出版: (2014)

ELUCIDATING THE ONCOGENIC ROLES OF MARCH5 IN MULTIPLE MYELOMA
由: HAMED BASHIRI
出版: (2024)

GENOME-WIDE PHARMACOLOGIC UNMASKING IDENTIFIES TUMOR SUPPRESSOR MICRORNAS IN MULTIPLE MYELOMA
由: BI CHONGLEI
出版: (2016)

Anti-myeloma effects of icariin are mediated through the attenuation of JAK/STAT3-dependent signaling cascade
由: Jung Y.Y., et al.
出版: (2019)

Sensitivity to inhibition by N-ethylmaleimide: A property of nitrobenzylthioinosine-sensitive equilibrative nucleoside transporter of murine myeloma cells
由: Lee, C.-W., et al.
出版: (2014)

Sensitivity to inhibition by N-ethylmaleimide: A property of nitrobenzylthioinosine-sensitive equilibrative nucleoside transporter of murine myeloma cells
由: Lee, C.-W., et al.
出版: (2016)

Carfilzomib and Dexamethasone vs Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma: Results of the Phase 3 Study ENDEAVOR (NCT01568866) According to Age Subgroup
由: Heinz Ludwig, et al.
出版: (2018)

IDENTIFY FUNCTIONAL PROTEINS INTERACTING WITH MMSET IN MULTIPLE MYELOMA
由: CHOOI JING YUAN
出版: (2018)

Targeting nf-κb signaling for multiple myeloma
由: Wong, A.H.-H., et al.
出版: (2021)

ELUCIDATING THE ROLE OF ADAR1 IN REGULATING IMMUNOTHERAPEUTIC RESPONSE IN MULTIPLE MYELOMA
由: KOH MUN YEE
出版: (2023)

IDENTIFICATION OF AN EFFECTIVE RIBONUCLEOSIDE ANALOGUE AND IMMUNOMODULATORY IMIDE DRUG COMBINATION FOR MULTIPLE MYELOMA
由: WEIJIE WANG
出版: (2024)

Ultrathin Porous NiFeV Ternary Layer Hydroxide Nanosheets as a Highly Efficient Bifunctional Electrocatalyst for Overall Water Splitting
由: Dinh, Khang Ngoc, et al.
出版: (2018)

O2 plasma and cation tuned nickel phosphide nanosheets for highly efficient overall water splitting
由: Dinh, Khang Ngoc, et al.
出版: (2020)